tiprankstipranks
Dhanlaxmi Crop Science Ltd. (IN:DHANLAXMI)
:DHANLAXMI
India Market

Dhanlaxmi Crop Science Ltd. (DHANLAXMI) AI Stock Analysis

1 Followers

Top Page

IN:DHANLAXMI

Dhanlaxmi Crop Science Ltd.

(DHANLAXMI)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
Action:ReiteratedDate:12/30/25
The score is primarily driven by solid growth and improved margins alongside low leverage, but is meaningfully constrained by poor cash flow quality (negative operating and free cash flow in FY25 and weak conversion in FY24). Technical and valuation inputs were not available, so they do not materially differentiate the score.
Positive Factors
Revenue Growth
The company's strong revenue growth trend indicates a robust market position and effective business strategies, supporting long-term expansion.
Negative Factors
Cash Flow Weakness
Negative cash flow despite positive earnings indicates potential liquidity issues, which could hinder the company's ability to fund operations and growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The company's strong revenue growth trend indicates a robust market position and effective business strategies, supporting long-term expansion.
Read all positive factors

Dhanlaxmi Crop Science Ltd. (DHANLAXMI) vs. iShares MSCI India ETF (INDA)

Dhanlaxmi Crop Science Ltd. Business Overview & Revenue Model

Company Description
Dhanlaxmi Crop Science Limited engages in the manufacturing and processing business of agriculture seeds in India. Its crop and vegetable seeds portfolio include cotton, wheat, cumin, bajra, maize, gram, okra, green gram, SSG, soyabean, milky, mus...
How the Company Makes Money
Dhanlaxmi Crop Science Ltd. generates revenue primarily through the sale of its crop protection products, including pesticides, herbicides, and fungicides, as well as fertilizers and high-yield seeds. The company's business model relies on a mix o...

Dhanlaxmi Crop Science Ltd. Financial Statement Overview

Summary
Strong revenue growth and improved profitability with conservative leverage support the score, but it is pulled down materially by weak cash conversion: operating and free cash flow were negative in FY25 (and weak in FY24) despite positive earnings, raising near-term liquidity and execution risk.
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
34
Negative
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue381.43M1.29B637.10M466.11M354.31M
Gross Profit145.15M208.60M121.98M85.64M55.26M
EBITDA81.28M126.13M68.78M44.94M15.32M
Net Income50.96M86.80M46.78M29.95M5.83M
Balance Sheet
Total Assets760.13M829.16M349.62M200.27M208.63M
Cash, Cash Equivalents and Short-Term Investments3.45M138.89M10.99M32.27M14.38M
Total Debt111.29M71.72M10.42M25.83M91.32M
Total Liabilities254.39M369.78M188.41M86.31M146.91M
Stockholders Equity505.74M459.38M161.21M113.96M61.73M
Cash Flow
Free Cash Flow-244.22M-141.43M-3.82M62.80M20.29M
Operating Cash Flow-217.16M-123.11M827.00K62.98M20.29M
Investing Cash Flow-24.19M-15.38M-4.63M-9.00K2.00K
Financing Cash Flow242.50M266.39M-17.48M-45.08M-12.02M

Dhanlaxmi Crop Science Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
59
Neutral
₹17.67B49.770.71%6.86%15.64%
58
Neutral
3.56
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:DHANLAXMI
Dhanlaxmi Crop Science Ltd.
IN:INSECTICID
Insecticides (India) Limited
607.25
-11.89
-1.92%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025